Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 255, pseudogene (RN7SL255P) is classified as a processed pseudogene related to the 7SL RNA family, which is the RNA component of the signal recognition particle (SRP). 7SL RNA is well-characterized for its role in the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum[1][3][5]. However, RN7SL255P itself is a pseudogene—not a protein-coding gene and not known to encode a functional RNA or protein product. Pseudogenes like RN7SL255P are generally regarded as genomic DNA elements resembling functional genes but are typically non-functional due to mutations or truncations[4]. They usually do not have a direct biological function, but some pseudogenes can play regulatory roles (e.g., acting as miRNA decoys or influencing gene expression by competitive endogenous RNA mechanisms), though there is no evidence that RN7SL255P has such a function in the literature or curated gene resources. RN7SL255P is not considered a therapeutic target such as a receptor, enzyme, transporter, or transcription factor, nor is it associated with known diseases, drug interactions, or safety considerations. No disease roles, biomarkers, or clinical utilities are reported for this pseudogene. There is also a potential nomenclature confusion: RN7SL255P is sometimes confused with functional genes like RN7SL1 (7SL RNA), which plays a critical role in the signal recognition particle[5]. The canonical 7SL RNA gene (RN7SL1, not RN7SL255P) is the relevant molecule for protein targeting and is involved in some pathological contexts, including cancer[5]. Summary: - RN7SL255P is a non-functional pseudogene. - It is not a receptor, enzyme, transporter, transcription factor, or other canonical therapeutic target. - There are no known disease associations, biological functions, drug interactions, or clinical biomarkers. - The main issue is that it is not a drug target, and confusion may arise from similarity in name to the functional 7SL RNA gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 255, pseudogene (RN7SL255P).